Trial Profile
An Eight-week, Randomized, Double-blind, Two Parallel Groups, Study to Assess Clinical Response of Duloxetine 60 mg and 120 mg Per Day in Patients Hospitalized for Severe Depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Oct 2023
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Depression; Major depressive disorder
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 05 Sep 2014 New trial record